Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, Southeast Asian, and Chinese β-thalassemia mutations

American Journal of Hematology

Volumn 78, Issue 4, 2005, Pages 249-255

  Bhardwaj, Urvashi ^a   Zhang, Yao Hua ^a   Lorey, Fred ^b   McCabe, Linda L ^a   McCabe, Edward R B ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STATE OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

thalassemia; Hemoglobinopathy; Molecular genetic confirmation; Newborn screening

Indexed keywords

AFRICAN AMERICAN; ARTICLE; ASIAN; BETA THALASSEMIA; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ETHNOLOGY; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMIGRATION; INDIAN; ISOELECTRIC FOCUSING; MOLECULAR GENETICS; NEWBORN; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHEAST ASIA; TAIWAN; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BETA-THALASSEMIA; CALIFORNIA; CHINA; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC SCREENING; HUMANS; INDIA; INFANT, NEWBORN; NEONATAL SCREENING; POLYMERASE CHAIN REACTION;

EID: 16344366025     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20269     Document Type: Article

References (26)

1. Nagal RL, Fleming AF. Genetic epidemiology of the beta gene. Baillieres Clin Haematol 1992;5:331-365.
2. Lorey F. Asian immigration and public health in California: thalassemia newborns in California. J Pediatr Hematol Oncol 2000;22:564-566.
3. Lorey F, Cunningham G. Impact of Asian immigration on thalassemia in California. Ann NY Acad Sci 1998;850:442-445.
4. Sickle Cell Disease Guidelines Panel. Sickle cell disease: screening, diagnosis, management, and counseling in newborns and infants. (Clinical Practice Guideline 6.) Rockville, MD: US Department of Health and Human Sciences; 1993.
5. Newborn Screening Committee, The Council of Regional Networks for Genetic Services (CORN). National Newborn Screening report 1995. Atlanta, GA: CORN; September 1999.
6. Davis SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. Screening for sickle cell disease and thalassemia: a systematic review with supplementary research. Health Technol Assess 2000;4:1-99.
7. Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol 1996;18:36-41.
8. McCabe ERB. Utility of PCR for DNA analysis from dried blood spots on filter paper blotters. PCR Methods Appl 1991;1:99-106.
9. th edition. Oxford: Blackwell Science; 2001. p 237-286.
10. Huisman THJ, Carver MFH, Baysal E. A syllabus of thalassemia mutations 1-309. Augusta, GA: The Sickle Cell Anemia Foundation; 1997.
11. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA: the amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-2516.
12. Ristaldi MS, Pirastu M, Rosatelli C, et al. Prenatal diagnosis of beta thalassemia in Mediterranean populations by dot blot analysis with DNA amplification and allele specific oligonucleotide probes. Prenat Diagn 1989;9:629-638.
13. Bhardwaj U, Zhang Y-H, McCabe ERB. Neonatal hemoglobinopathy screening: molecular genetic technologies. Mol Genet Metab 2003;80:129-137.
14. Orita M, Suzuki Y, Sekiya T, Hayaski K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-879.
15. Losekoot M, Fodde R, Harteveld CL, van Heeren H, Giorano PC, Bernini LF. Denaturing gradient gel electrophoresis and direct sequencing of the PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassemia. Br J Hematol 1990;76:269-274.
16. Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of β-thalassemia. Studies in Indian and Cypriot population in the UK. Lancet 1990:336:834-837.
17. Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of β- thalassemia mutations on the Indian subcontinent: the basis of prenatal diagnosis. Br J Hematol 1991;78: 242-247.
18. Chang JG, Lin CP, Liu TC, et al. Molecular basis of beta thalassemia minor in Taiwan. Int J Hematol 1994;59:267-272.
19. Kazazian HH Jr, Dowling CE, Waber PG, Huang S, Lo WHY. The spectrum of β-thalassemia genes in China and Southeast Asia. Blood 1986;68(4):964-966.
20. Tan KL, Tan JAMA, Wong YC, Wee YC, Thong MK, Yap SF. Combine-ARMS: a rapid and cost effective protocol for molecular characterization of β-thalassemia in Malaysia. Genet Test 2001;5: 17-22.
21. Sylvester-Jackson DA, Page SL, White JM, et al. Unbiased analysis of the frequency of β-thalassemia point mutations in a population of African-American newborns. Arch Pathol Lab Med 1993; 117:1110-1114.
22. Reed W, Lane PA, Lorey F, et al. Sickle cell disease not identified by newborn screening because of prior transfusion. J Pediatr 2000;136:145-146.
23. Wilborn M, Therrell BL, McCabe ERB. Newborn screening for sickle cell disease in transfused infants. National Newborn Screening Meeting, June 7-11, Seattle, Washington, 1994.
24. Chang JG, Liu HJ, Huang HM, Yang TY, Chang CP. Multiplex mutagenically separated PCR: diagnosis of β-thalassemia and hemoglobin variants. BioTechniques 1997;22:520-527.
25. Caggana M, Conroy JM, Pass KA. Rapid, efficient method for multiplex amplification from filter papers. Hum Mutat 1998;11:404-409.
26. Zhang Y-H, McCabe ERB. RNA analysis from newborn screening dried blood specimens. Hum Genet 1992;89:311-314.